Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04936841 · TERMINATED
Trial details
- NCT number
- NCT04936841
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2022-10-04
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.